Stefania M.
- Country
- Italy
- Department
- 039022: UOC Oncologia Medica
Research Overview
Data & Insights
Has run more than one trial at 0 of 204 partner sites.
Specializations
Breast Cancer Research
This investigator specializes in studying early-stage breast cancer with a particular focus on hormone receptor-positive disease. Their research concentrates on improving treatment outcomes for patients with node-positive breast cancer who face elevated recurrence risks.
- Hormone-Dependent Breast Cancer
- Early-Stage Disease Management
- High-Risk Patient Populations
The investigator explores therapeutic approaches for HER2-negative breast cancer, particularly examining endocrine therapy strategies.
Endocrine Therapy
The investigator focuses on advancing endocrine treatment modalities for breast cancer patients. Their work encompasses evaluation of both standard and novel therapeutic approaches in hormone receptor-positive malignancies.
- Novel Endocrine Agents
- Treatment Optimization
- Therapeutic Resistance
Their research extends to investigating comparative effectiveness of different hormonal treatment strategies in high-risk populations.
Clinical Outcomes
The investigator's work centers on evaluating disease-free survival metrics and improving patient outcomes. They specialize in studying invasive breast cancer recurrence patterns and developing strategies for risk reduction.
- Survival Analysis
- Recurrence Prevention
- Risk Assessment
Their research aims to enhance understanding of treatment efficacy markers in breast cancer therapy.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.